Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center officials violated conflict of interest policies
April 5, 2019Medical Communications, Research and Development Cancer, Memorial Sloan Kettering Cancer Center, oncology, research
Top officials at the Memorial Sloan Kettering Cancer Center repeatedly violated policies on financial conflicts of interest, according to details …
Takeda unveils three new discovery and development collaborations in immuno-oncology
January 4, 2019Medical Communications, Research and Development CAR-T, Crescendo Biologics, Memorial Sloan Kettering Cancer Center, Noile-Immune, Takeda, pharma
Takeda has revealed that it is set to bolster its novel immuno-oncology portfolio with three new research collaborations. The Japanese …
Memorial Sloan Kettering Chief resigns from MSD board
October 3, 2018Research and Development MSD, Memorial Sloan Kettering Cancer Center, pharma
Dr Craig Thompson, Chief Executive of Memorial Sloan Kettering Cancer Center (MSKCC), the renowned non-profit treatment and research institution based …
Avacta joins major US cancer centre for CAR-T immunotherapy development
November 2, 2016Research and Development Avacta, Memorial Sloan Kettering Cancer Center
Biotherapeutic and research reagent developer Avacta has announced it will collaborate with New York’s Memorial Sloan Kettering Cancer Center (MSK, …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
